| Wayne Belling, DO | |
|
3403 159th St, Urbandale, IA 50323-2482 | |
| (515) 528-6682 | |
| Not Available |
| Full Name | Wayne Belling |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 3403 159th St, Urbandale, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083626063 | NPI | - | NPPES |
| 9085167 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02729 (Iowa) | Primary |
| Entity Name | St Anthony Regional Hospital And Nursing Home |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891711925 PECOS PAC ID: 4688586829 Enrollment ID: O20031105000218 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
| Entity Name | Pocahontas Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609989581 PECOS PAC ID: 7012820012 Enrollment ID: O20031106000417 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
| Entity Name | Stewart Memorial Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285652909 PECOS PAC ID: 4486563707 Enrollment ID: O20031107000249 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
| Entity Name | Pocahontas Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1346241213 PECOS PAC ID: 7012820012 Enrollment ID: O20061104000292 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
| Entity Name | Loring Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003965336 PECOS PAC ID: 1052379625 Enrollment ID: O20080313000229 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wayne Belling, DO 3403 159th St, Urbandale, IA 50323-2482 Ph: (515) 528-6682 | Wayne Belling, DO 3403 159th St, Urbandale, IA 50323-2482 Ph: (515) 528-6682 |
News Archive
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.
Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."
Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.
› Verified 4 days ago
Scott Thomas Hanson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4003 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-237-3985 Fax: 515-237-3994 | |
James Raymond Bell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2901 86th St, Urbandale, IA 50322 Phone: 515-276-3406 Fax: 515-276-5141 | |
Dr. Shawn Spooner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 86th St, Urbandale, IA 50322 Phone: 515-276-3406 | |
Audrey Porter, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2413 71st St, Urbandale, IA 50322 Phone: 515-278-9595 Fax: 515-278-2329 | |
Kimberley P Bauman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 Aurora Ave, Urbandale, IA 50322 Phone: 515-270-1177 Fax: 515-643-9361 | |
Andrew Joseph Mcmurray, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4323 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-875-9190 Fax: 515-875-9202 |